Literature DB >> 20919384

Clinical profile of cefuroxime in sixty-four patients.

P Hänninen, H Saarimaa, P Toivanen, A Kasanen.   

Abstract

Entities:  

Year:  1977        PMID: 20919384      PMCID: PMC1543254     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  5 in total

1.  Cefuroxime: pharmacokinetics after a short infusion, and in vitro activity against hospital pathogens.

Authors:  C S Goodwin; C H Dash; J P Hill; A D Goldberg
Journal:  J Antimicrob Chemother       Date:  1977-05       Impact factor: 5.790

2.  Cefuroxime: human pharmacokinetics..

Authors:  R D Foord
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

3.  Cefuroxime, a new cephalosporin antibiotic: activity in vivo.

Authors:  D M Ryan; C O'Callaghan; P W Muggleton
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

4.  Cefuroxime, a new cephalosporin antibiotic: activity in vitro.

Authors:  C H O'Callaghan; R B Sykes; A Griffiths; J E Thornton
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

5.  Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole.

Authors:  S Eykyn; C Jenkins; A King; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

  5 in total
  3 in total

Review 1.  Cefuroxime: a review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

2.  Comparison of cefuroxime and penicillin in the treatment of uncomplicated gonorrhea.

Authors:  J G Lossick; S E Thompson; M P Smeltzer
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

3.  Pharmacokinetics and clinical effects of cefuroxime in patients with severe renal insufficiency.

Authors:  R A Walstad; O G Nilsen; K J Berg
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.